Roivant Sciences Ltd at Leerink Global Healthcare Conference Transcript
Hi, everybody. So my name is Dave Risinger. On behalf of Leerink Partners. I just wanted to thank you for joining our conference. It's very much my pleasure to introduce Matt Gline, CEO of Roivant.
He's just putting a little sugar in his coffee and then we'll get started. But I really appreciate you being here and his team members Richard and -- in the audience as well.
So I thought it would be great for you to just maybe kick off Matt with some opening comments on the business prospects, you've had a tremendous run of good news and hoping for good -- for more good news ahead, but I would love you to start with some opening comments.
Yes. Thanks, Dave. Thanks for having us. It's a great venue for a conference. I think the best in Miami at present.
So thanks, Dave. Thank you for having us.
Look, it's been -- I don't know what's hard looking at over the room to know exactly who's got what level of familiarity, but
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

